ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2017 American Transplant Congress

    How Potential Living Kidney Donors (LKDs) View ESRD Risk: A Multi-Center Study.

    C. Thiessen,1 G. Gannon,1 D. Gray,2 K. Kennedy,3 D. Dobosz,1 S. Li,1 K. Yu,1 A. Mussell,2 E. Gordon,3 P. Reese,2 S. Kulkarni.1

    1Yale U, New Haven; 2U Pennsylvania, Philadelphia; 3Northwestern U, Chicago

    PurposeTo determine how kidney donors view ESRD risk at initial donor evaluation.MethodsWe conducted a longitudinal, prospective study of LKDs at three centers and report results…
  • 2017 American Transplant Congress

    Effect of AKI Donor Admit Creatinine on Renal Transplant Outcomes.

    E. Giorgakis,1 R. Heilman,2 H. Khamash,2 B. Kaplan,2 A. Moss,1 M. Smith,3 K. Reddy.1

    1Department of Surgery, Mayo Clinic, Phoenix, AZ; 2Department of Medicine, Mayo Clinic, Phoenix, AZ; 3Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ

    Purpose of the study was to explore the effect of admit AKI donor creatinine on graft outcomes.Method: Single center retrospective analysis of kidney transplants performed…
  • 2017 American Transplant Congress

    The New Kidney Allocation System: The Effect on Elderly Transplantation in the US. Review of UNOS Database.

    V. Whittaker, M. Laftavi, Z. Acun, R. Gruessner, A. Gruessner.

    Surgery, State University New York, Syracuse, NY

    The New Kidney Allocation System(KAS) improve access disadvantaged groups. The effect on the elderly population, recipients >=65 is unknown.Methods: Retrospective analysis of UNOS database preKAS…
  • 2017 American Transplant Congress

    Association with Tacrolimus Intraindividual Variability, Acute Microinflammation Based on 1 Year-Transplanted Kidney Biopsy After Transplantation, and Biopsy-Proven Acute Rejection.

    S.-Y. Kim, S.-I. Min, W. Cho, S. Cho, M.-J. Cho, S. Ahn, S.-K. Min, J. Ha.

    Surgery, Seoul National University College of Medicine, Seoul, Korea

    Background: The purpose of this study was to investigate relationship between tacrolimus intraindividual variability (IIV), acute microinflammation (AMI) based on 1 year-transplanted kidney biopsy, and…
  • 2017 American Transplant Congress

    Incidence of De Novo Donor-Specific Antibodies Following Kidney Transplantation.

    B. Ho,1 H. Bhagat,2 E. Lee,2,3 K. Atiemo,1 A. Daud,1 R. Kang,1 S. Montag,1,4 L. Zhao,1,4 J. Schwartz,2 D. Ladner.1

    1Northwestern University Transplant and Outcomes Research Collaborative (NUTORC), Chicago; 2Astellas Pharma Global Development, Northbrook; 3Now with UCB, Atlanta; 4Dept of Preventive Medicine, Northwestern University, Chicago

    With a range of frequencies reported in several small studies, true incidence of de novo donor-specific human leukocyte antigen (HLA) antibodies (dnDSA) is unknown. As…
  • 2017 American Transplant Congress

    Pre-Transplant Circulating TNFR2+ Regulatory T Cells Predict Acute Rejection within the First 6 Months After Kidney Transplantation.

    M.-T. Nguyen,1 S. Sahakian,2 S. Liu,2 Y. Wang,2 J. Tchervenkov,2 S. Paraskevas.2

    1Department of Surgery, Columbia University, New York, NY; 2Department of Surgery, McGill University, Montreal, QC, Canada

    Background: Acute rejection (AR) mostly occurs during the first 6 months after kidney transplantation and contributes importantly to graft loss. Diagnosis relies on changes in…
  • 2017 American Transplant Congress

    Ambulatory Antibiotic Utilization and Outcomes in an Adult Kidney Transplant Population: A Pharmacovigilance Analysis.

    L. Avery, C. Fominaya, R. Crawford, D. Taber.

    Pharmacy, Ralph H Johnson VAMC, Charleston, SC

    Antibiotics (abx) are commonly prescribed to kidney transplant (KTX) recipients in the outpatient setting. There is limited data assessing the safety and outcomes associated with…
  • 2017 American Transplant Congress

    Treating Ischemically Damaged Porcine Kidneys with Mesenchymal Stromal Cells During Normothermic Machine Perfusion.

    M. Pool,1 J. Sierra Parraga,2 M. Roemeling-van Rhijn,3 M. Reinders,4 M. Hoogduijn,2 R. Ploeg,1,5 H. Leuvenink,1 C. Moers.

    1Surgery, UMCG, Groningen, Netherlands; 2Internal Medicine, Erasmus Medical Center, Rotterdam, Netherlands; 3Internal Medicine, UMCG, Groningen, Netherlands; 4Nephrology, LUMC, Leiden, Netherlands; 5Oxford Transplant Centre, University of Oxford, Oxford, United Kingdom

    Normothermic machine perfusion (NMP) could provide superior organ preservation and offers the unique opportunity for interventions to an isolated kidney prior to transplantation. There is…
  • 2017 American Transplant Congress

    Analysis of Differences in Living Donor and Recipient Pairs Estimated GFR at Six Months Over Time.

    D. Keith.

    Medicine, Division of Nephrology, Sacred Heart Hospital, Pensacola, FL

    Previous studies of the United States Kidney Transplant Database revealed that the median estimated GFR (eGFR) has improved over the last decade for living donor…
  • 2017 American Transplant Congress

    Experience with Obinutuzumab (Type II Anti-CD20) in Kidney Transplant Patients with Donor Specific Antibody (DSA+) Antibody Mediated Rejection.

    J. Choi, A. Vo, E. Huang, S. Louie, A. Kang, A. Peng, R. Najjar, S. Jordan.

    Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA

    Introduciton:Rituximab is a type I chimeric IgG1 anti-CD20 antibody that has revolutionized the management and treatment of B-cell malignancies, and numerous autoimmune diseases. In addition,…
  • « Previous Page
  • 1
  • …
  • 343
  • 344
  • 345
  • 346
  • 347
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences